InspireMD Inc (id:6242 NSPR)
2.86 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/25/2024 11:04:25 AM)
Exchange open, closes in 4 hours 55 minutes
About InspireMD Inc
Market Capitalization 76.69M
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
| Headquarters (address) |
4 Menorat Hamaor Street Tel Aviv 6744832 Israel |
| Phone | 972 3 6917691 |
| Website | https://www.inspiremd.com |
| Employees | 65 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | NSPR |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 1.81 - 3.42 |
| Market Capitalization | 76.69M |
| P/E trailing | -3.49 |
| P/E forward | -4.14 |
| Price/Sale | 11.24 |
| Price/Book | 1.83 |
| Beta | 3.00 |
| EPS | 3.00 |
| EPS Israel (ID:92, base:52) | 3.00 |